BioWorld

Aug. 31, 2006

View Archived Issues

Genzyme Wants AnorMed For $380M; AnorMed Uninterested

After AnorMed Inc.'s board rejected an unsolicited $380 million takeover bid, Genzyme Corp. said it plans to go to AnorMed shareholders with a proposal to acquire the company. (BioWorld Today) Read More

OrthoLogic's Stock Dips As Phase IIb Misses Endpoint

Read More

P38 MAP Kinase Block May Foil One More Autoimmune Disorder

Read More

Roche Returns Zenapax Rights In Asthma To PDL

Read More

Clinic Roundup

Read More

Other News To Note

Read More